SEEK ID: https://ldh-dzkj.vm.gwdguser.de/people/1
Locations:
United Kingdom
,
Germany
ORCID: Not specified
Joined: 7th Jul 2026
Expertise: Not specified
Tools: Not specified
Roles
Admin
Project administrator
- LDH-UMG-Goettingen
- Influence of life-style factors on the development of the immune system and allergies in East and West Germany
- German Infant Study on the Influence of Nutrition Intervention plus Air pollution and Genetics on Allergy Development
- German Infant Study on the influence of Nutrition Intervention
- Ulm SPATZ Health Study
- Primary Oral Insulin Trial
- Supplementation with B. infantis to mitigate Type 1 Diabetes Autoimmunity
- Cross-Sectional asthma cohort
- Test
Their tagsThis person has not yet tagged anything.
Related items
The LISA study is an ongoing, long-term, population-based prospective birth cohort study comprising 3094 children from four regions of Germany (Munich, Leipzig, Wesel, Bad Honnef). The aims of the LISA study are to monitor the development and natural course of atopic diseases and to investigate the influence of life-style and environmental factors. The study further collects information on mental well-being, lung function, nutrition, body composition and physical activity, contributing to a better ...
Public web page: Not specified
Organisms: Not specified
Das allergische Asthma bronchiale im Kindesalter wird als Fehlregulation des Immunsystems zugunsten eines pro-allergischen Th2-Phänotyps beschrieben. Das Th2/Th1-Ungleichgewicht könnte durch eine Fehlregulation der regulatorischen T-Zellen und möglicherweise auch in Interaktion mit den pro-inflammatorischen Th17-Zellen zustande kommen. Klinisch relevant ist neben dem allergischen jedoch auch der nicht-allergische Phänotyp. Der Schwerpunkt dieses Projekts liegt daher auf der Untersuchung der ...
Public web page: Not specified
Organisms: Not specified
The GPPAD-04 SINT1A study will evaluate whether early, regular supplementation with a daily dose of a probiotic can reduce the risk of developing beta-cell autoimmunity in children identified by GPPAD-02 as being genetically predisposed to developing type 1 diabetes. Children will be enrolled at age 7 days to 6 weeks (+14 days) and the study product (B. infantis EVC001 or Placebo) will be administered orally once per day from enrollment until age 12 months (+14 days). The hypotheses is that ...
Public web page: Not specified
Organisms: Not specified
The GPPAD-POInT-Study aims to determine whether daily administration of oral insulin to children from age 4 months - 7 months with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies and diabetes in childhood. The purpose of the GPPAD-POInT-Study is to induce immune tolerance to beta-cell autoantigens through regular exposure to oral insulin for a period of 29 to 32 months. Together with the results of the Pre-POINT-Early Study, this phase IIb ...
Public web page: Not specified
Organisms: Not specified
ROR ID: Not specified
Department: Not specified
Country:
United Kingdom
City: Not specified
Web page: Not specified
ROR ID: https://ror.org/021ft0n22
Department: Not specified
Country:
Germany
City: Göttingen
Web page: https://www.umg.eu/
ROR ID: https://ror.org/01y9bpm73
Department: Not specified
Country:
Germany
City: Göttingen
Web page: http://www.uni-goettingen.de/en/1.html